• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

睾丸癌的死亡率:单中心10年经验

Mortality in testicular cancer: 10 years' experience at a single centre.

作者信息

Germa J R, Mercedes A, Tabernero J M, Palou J, Algaba F, Villavicencio H, Sole F J

机构信息

Department of Medical Oncology, Hospital de Sant Pau, Barcelona, Spain.

出版信息

Urol Int. 1996;57(1):32-7. doi: 10.1159/000282873.

DOI:10.1159/000282873
PMID:8840488
Abstract

The aim of the present study was to investigate the causes of death in patients with germ cell testicular tumours (GCTTs), especially those due to persistent or recurrent tumours, and to determine potentially avoidable deaths. Among 299 patients with GCTTs there were 27 (9%) deaths: 21 (78%) had non-seminomatous GCTTs and 6 (22%) had seminomatous GCTTs. Sixteen deaths (59%) were due to progressive disease, 6 (22%) were treatment-related, 4 (15%) were due to incidental causes, and 1 was a sudden, unexplained death. The analysis of the data led us to the conclusion that some deaths are still potentially avoidable.

摘要

本研究的目的是调查睾丸生殖细胞肿瘤(GCTT)患者的死亡原因,尤其是那些由持续性或复发性肿瘤导致的死亡原因,并确定可能避免的死亡情况。在299例GCTT患者中,有27例(9%)死亡:21例(78%)为非精原细胞瘤性GCTT,6例(22%)为精原细胞瘤性GCTT。16例死亡(59%)是由于疾病进展,6例(22%)与治疗相关,4例(15%)是由于偶然原因,1例是突然的、原因不明的死亡。数据分析使我们得出结论,一些死亡仍然有可能避免。

相似文献

1
Mortality in testicular cancer: 10 years' experience at a single centre.睾丸癌的死亡率:单中心10年经验
Urol Int. 1996;57(1):32-7. doi: 10.1159/000282873.
2
[Frequency and cause of death in patients with testicular germinal tumors at our center: retrospective analysis].[我院睾丸生殖细胞肿瘤患者的死亡频率及原因:回顾性分析]
Arch Esp Urol. 2002 Mar;55(2):153-63.
3
A Scottish national mortality study assessing cause of death, quality of and variation in management of patients with testicular non-seminomatous germ-cell tumours. The Scottish Radiological Society and the Scottish Standing Committee of the Royal College of Radiologists.一项苏格兰全国性死亡率研究,评估睾丸非精原细胞瘤生殖细胞肿瘤患者的死因、治疗质量及差异。苏格兰放射学会和皇家放射科医师学院苏格兰常务委员会。
Br J Cancer. 1995 Nov;72(5):1307-11. doi: 10.1038/bjc.1995.506.
4
Cure without complications: a population-based analysis of treatment intensity and survival in testicular germ cell tumours.无并发症治愈:基于人群的睾丸生殖细胞肿瘤治疗强度与生存分析
Clin Oncol (R Coll Radiol). 2003 Apr;15(2):84-5. doi: 10.1053/clon.2002.0195.
5
Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumours.大体积播散性非精原细胞性生殖细胞肿瘤患者的交替剂量密集化疗。
Br J Cancer. 2002 May 20;86(10):1555-60. doi: 10.1038/sj.bjc.6600272.
6
[Progress in the treatment of germ cell tumor of the testis].[睾丸生殖细胞肿瘤的治疗进展]
Actas Urol Esp. 2002 Nov-Dec;26(10):759-62. doi: 10.1016/s0210-4806(02)72854-4.
7
Germ cell tumours of the testis: clinical features, treatment outcome and prognostic factors.睾丸生殖细胞肿瘤:临床特征、治疗结果及预后因素
Natl Med J India. 2002 Jan-Feb;15(1):18-21.
8
Germ-cell tumor survivors: the price for cure.
Ann Oncol. 2002 Feb;13(2):187-9. doi: 10.1093/annonc/mdf126.
9
Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group.一线序贯大剂量依托泊苷、异环磷酰胺和顺铂化疗联合自体干细胞支持治疗晚期转移性生殖细胞癌患者的长期结果:德国睾丸癌研究组的一项扩展I/II期研究
J Clin Oncol. 2003 Nov 15;21(22):4083-91. doi: 10.1200/JCO.2003.09.035. Epub 2003 Oct 20.
10
Germ cell testis cancer: 15-year review.睾丸生殖细胞癌:15年回顾。
J Surg Oncol. 1996 May;62(1):30-3. doi: 10.1002/(SICI)1096-9098(199605)62:1<30::AID-JSO7>3.0.CO;2-S.